Vivos Therapeutics, Inc. Quarterly Operating Lease, Payments in USD for Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Vivos Therapeutics, Inc. quarterly/annual Operating Lease, Payments history and growth rate for Q1 2024.
  • Vivos Therapeutics, Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $153K.
  • Vivos Therapeutics, Inc. annual Operating Lease, Payments for 2023 was $602K, a 37.4% increase from 2022.
Operating Lease, Payments, Quarterly (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $153K Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.